NIH-funded research NIH-funded research

Improving blood sample processing methods for studying sepsis

Official title: Optimizing methods of clinical sample processing for scRNA-seq and mechanistic studies in sepsis to enable reliable, reproducible, and high-yield multi-center collection efforts

Funded at Massachusetts General Hospital · NIH-11228618 · Data updated 2026-11-12

This study is looking at how to improve the way we analyze blood samples from people with sepsis, a serious infection-related condition, to better understand their immune responses and help doctors provide more personalized treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2026
Funding year2025
Award (this year)$676,179
NIH project number4R33GM148826-03
Project IDNIH-11228618 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with sepsis or at risk of developing sepsis.

Less likely to help

Patients with conditions unrelated to sepsis or those who do not require hospitalization may not benefit from this research.

What this research studies

This research focuses on enhancing the processing of clinical blood samples to better understand sepsis, a serious condition caused by the body's response to infection. By utilizing advanced techniques like single-cell RNA sequencing (scRNA-seq), the study aims to identify specific immune cell responses in sepsis patients, which can vary widely. The goal is to create a reliable method for collecting and analyzing samples across multiple centers, ultimately leading to more accurate diagnoses and treatments for sepsis. Patients' immune responses will be characterized in detail, helping to tailor therapies to individual needs.

Why it matters

Potential benefit: If successful, this research could lead to more precise and effective treatments for sepsis, improving patient outcomes.

How similar studies have gone: Previous research has successfully utilized single-cell RNA sequencing to identify immune responses in various conditions, indicating a promising approach for sepsis as well.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Filbin, Michael — Massachusetts General Hospital
  • Study coordinator: Filbin, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.